The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic.

Genome Med
Authors
Abstract

Clinical whole-genome sequencing (WGS) offers clear diagnostic benefits for patients with rare disease. However, there are barriers to its widespread adoption, including a lack of standards for clinical practice. The Medical Genome Initiative consortium was formed to provide practical guidance and support the development of standards for the use of clinical WGS.

Year of Publication
2020
Journal
Genome Med
Volume
12
Issue
1
Pages
48
Date Published
2020 May 27
ISSN
1756-994X
DOI
10.1186/s13073-020-00748-z
PubMed ID
32460895
Links